Chiara Varamo

Candiolo Cancer Institute — Italy

Medicine · Health Sciences

9h-index403citations21works27.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(9), Cholangiocarcinoma and Gallbladder Cancer Studies(6), CAR-T cell therapy research(4), Drug Transport and Resistance Mechanisms(3), Effects of Radiation Exposure(3)

Publications20 total

Doxycycline Restores Gemcitabine Sensitivity in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
Cancers·2025· 3 citedOpen Access
Nucleotide metabolism in cancer cells fuels a UDP-driven macrophage cross-talk, promoting immunosuppression and immunotherapy resistance
Nature Cancer·2024· 51 citedOpen Access
Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma
Frontiers in Oncology·2022· 6 citedOpen Access
Evolution of the Experimental Models of Cholangiocarcinoma
Cancers·2020· 94 citedOpen Access
Abstract 533: The immune landscape in colon cancer and its changes after radiotherapy
Cancer Research·2019
Abstract 533: The immune landscape in colon cancer and its changes after radiotherapy
Immunology·2019
Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line Resistant to Gemcitabine
Cancers·2019· 28 citedOpen Access
Activation of immune response in refractory patients to standard treatment (T.R.A.N.S.L.A.T.E.)
Infinite Science GmbH·2018Open Access
Analysis of miRNAs and their correlation with early malignat melanoma (MM)
Annals of Oncology·2017Open Access
Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy
Cancer Immunology Immunotherapy·2017· 49 citedOpen Access
Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts
Journal of Translational Medicine·2017· 43 citedOpen Access
Tumor-infiltrating lymphocytes (TILs) density as prognostic determinant in stage II colorectal cancer
Annals of Oncology·2016· 1 cited
Individual ADCC capability predict treatment outcome under cetuximab-based therapy in head and neck cancer?
Annals of Oncology·2016
Prognostic value of hpv infection by e1 detection and p16 expression in 78 oropharyngeal squamous cell carcinomas
Annals of Oncology·2016Open Access
Individual ADCC capability predict treatment outcome under cetuximab-based therapy in head and neck cancer?
Annals of Oncology·2016
Screening of malignant melanoma (MM) by miRNA: preliminary data on incidence after initial clinical evaluation
Annals of Oncology·2016Open Access
MicroRNAs role as potential biomarkers and key regulators in melanoma
Genes Chromosomes and Cancer·2016· 46 cited
Preclinical activity of EGFR and MEK1/2 inhibitors in the treatment of biliary tract carcinoma
Oncotarget·2016· 14 citedOpen Access
T memory cells in the tumor invasive margins affect survival in colon cancer (CC) but not in breast cancer (BC).
Journal of Clinical Oncology·2016
Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient
Tumor Biology·2015· 40 citedOpen Access

Frequent Co-authors

Daniela Vivenza(10), Cristiana Lo Nigro(10), Marco Merlano(9), Massimo Aglietta(8), Laura Lattanzio(8), Caterina Peraldo‐Neia(6), Giuliana Cavalloni(6), Marcella Occelli(6), Francesco Leone(5), Paola Bernabei(4), Vincenzo Ricci(4), Ornella Garrone(4), Annamaria Massa(3), Francesca Vita(3), Nerina Denaro(3), G. Milano(3), Carolina Cauchi(3), Grazia Sciancalepore(3), Michela Rovera(3), Zelda Seia(3)